Skip to content

Small Cap Stocks: Rockfire Resources, Fusion Antibodies, Oracle Power

Small Cap Stocks: Rockfire Resources, Fusion Antibodies, Oracle Power

London’s AIM All Share index may have been rangebound but despite the broader economic narrative, managed to make some modest progress during the day, reaching the close up one and a half points at 736.62.

  • Rockfire Resources +77%
  • Fusion Antibodies +39%
  • Surface Transforms +24%
  • Oracle Power -31%
  • Oxford Biodynamics -30%

Rockfire Resources LON:ROCK was the best performer on the day, up 77% by the bell. The company published a note this morning advising that China had banned all Germanium exports to the USA, something that could have significant consequences for the company’s 100% owned zinc mine in Greece. Germanium is seen as a potential by-product here, although there’s still more work to be done in assessing the rare earth content of this site.


Fusion Antibodies LON:FAB was 39% higher after noting grant funding approval had been secured. The money will be used by Fusion to cover human resource needs, materials/consumables costs and capital investment, and gives the company access to facilities, equipment, staff and expertise made available under the Grant.

Surface Transforms LON:SCE was 24% higher to take the notable mention. It’s the second time this week the stock has made it onto our radar although the only news in play is a notification of an investor selling down a stake.

Oracle Power LON:ORCP was 31% lower on the day. Shares jumped at the start of the week in anticipation of a news release. That materialised this morning but seems to have been a trigger for many to book profits, using the buy the rumour, sell the fact approach. Volumes have been very high.

Oxford Biodynamics LON:OBD was off 30%, in second to last place. As we noted yesterday, management ended up issuing a note last night regarding Tuesday’s share price movement and with no progress here, evidently profit takers came out in force. The stock is still up almost 50% from this time last week.

*Note I see that last night I incorrectly referred to Oxford Biomedica LON:OXB, rather than Oxford Biodynamics. My apologies for any confusion this may have caused.

Share this article

Invest with these platforms

Hargreaves Lansdown

IG

Interactive Brokers

Interactive Investor

Charles Stanley

IG

Interactive Brokers

Charles Stanley

Looking for great investing ideas? Get our free newsletter.
Join our UK news channel on WhatsApp

This article does not constitute investment advice.  Do your own research or consult a professional advisor.

Learn with our free 'How to' Guides

Our latest in-depth company reports

On the podcast

Sign up for great investing stock tips

Thanks to our Site Partners

Our partners are established, regulated businesses and we are grateful for their support.

Aquis
CME Group
FP Markets
Pepperstone
Admiral Markets

TMX
WisdomTree
ARK
FxPro
CMC Markets
Back To Top